Battle lines are being drawn between establishment Democrats and progressive liberals in Congress over the idea of single-payer healthcare; an antitrust lawsuit filed in 2016 by states over 2 generic drugs has expanded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs; HHS will consider whether to approve work requirements for Medicaid expansion in Virginia.
Battle lines are being drawn between establishment Democrats and progressive liberals in Congress over the idea of single-payer healthcare. The partnership that helped Democrats save the Affordable Care Act a year ago is falling apart, Politico reported. Hospital associations, insurance groups, and other lobbies have teamed up to stop the idea of expanding Medicare for All, favored by progressives. The dispute could come into full view when Democrats take over the House of Representatives in January.
An antitrust lawsuit filed in 2016 by states over 2 generic drugs has expanded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs, The Washington Post reported. Executives at generic drug companies had their own shorthand to describe how they divvied up the market and set prices, according to the investigation. In one example, prices for albuterol soared more than 3400%.
HHS will consider whether to approve work requirements for Medicaid expansion in Virginia, The Hill reported. Expanding Medicaid was a top goal of Democratic Governor Ralph Northam, but Republicans agreed to support the expansion only if it came with work requirements. The proposal would be phased in, with some adults required to work 20 hours per month, increasing to 80 hours per month after 1 year, with some exceptions. As with other states, failure to comply would result in a loss of health coverage.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen